Skip to main content

Table 1 Characteristics of patients

From: Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure

Variables NYHA class I NYHA class II NYHA class III NYHA class IV
  N = 16 N = 25 N = 30 N = 30
Age, y 66.3 ± 8.1 66.9 ± 8.1 68.5 ± 7.6 68.7 ± 10.6
BMI, kg/m2 28.8 ± 4.5 29.0 ± 3.5 27.3 ± 4.4 29.3 ± 6.2
WBC, 103/mm3 7.1 ± 1.9 8.2 ± 1.8 8.1 ± 2.2 10.6 ± 4.1
LVEF, % 51.1 ± 14.8 37.0 ± 12.6 31.1 ± 9.8 33.8 ± 13.6
LVDd, mm 58.1 ± 9.8 64.0 ± 13.0 62.6 ± 10.2 59.6 ± 6.8
VO2 peak, ml × kg-1 × min-1 22.3 ± 10.4 19.0 ± 4.3 17.9 ± 4.8 12.0 ± 2.1
BNP, pmol/l 32.4 ± 33.2 85.7 ± 83.5 222 ± 204 474 ± 461
Underlying heart disease, n     
   -DCM 3 (19%) 9 (36%) 2 (7%) 3 (10%)
   -Hypertension 6 (38%) 4 (16%) 8 (27%) 0 (0%)
   -CAD 5 (31%) 10 (40%) 16 (53%) 20 (67%)
   -Myocarditis 1 (6%) 0 (0%) 0 (0%) 0 (0%)
   -others 1 (6%) 2 (8%) 4 (13%) 7 (23%)
Diabetes mellitus, n 5 (31%) 12 (48%) 13 (43%) 11 (37%)
Smoking, n 4 (25%) 4 (16%) 1 (3%) 3 (10%)
Statin, n 7 (44%) 10 (40%) 16 (53%) 18 (60%)
  1. Values are mean ± SD or number of patients. BMI, body mass index; WBC, white blood cells; LVEF, left ventricular ejection fraction; BNP, B-type natriuretic peptide; DCM, dilatative cardiomyopathy; CAD, coronary artery disease; NYHA, New York Heart Association.